NCT01765439View on ClinicalTrials.gov

The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions
Crohn DiseaseUlcerative Colitis
Interventions
DIETARY_SUPPLEMENT

VSL#3 (Original De Simone formulation)

Study subjects will receive two sachets of VSL#3 probiotic (ie 2x900 billions of live bacteria) per day (one in the morning, one in the evening). The intervention period will be 6 weeks (plus or minus 5 days).

Trial Locations (1)

17004

Iscare I.V.F., Prague

All Listed Sponsors
collaborator

Iscare i.v.f., Czech Republic

UNKNOWN

collaborator

CD Investments srl

UNKNOWN

collaborator

University Of Perugia

OTHER

collaborator

University of Roma La Sapienza

OTHER

lead

Charles University, Czech Republic

OTHER

NCT01765439 - The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter